All you need to know about COVID-19 Vaccine


Normally, the Food and Drug Administration approves any vaccine but in the case of COVID-19, vaccine makers will apply for emergency use authorization (EUA) to bypass the six months follow-up study and release the vaccine in the emergency. According to vaccine makers, the same scientific process was followed to create the COVID-19 vaccine that goes into developing any vaccine but the development process was sped up. Studies so far show that the vaccine can only protect against getting sick with the disease and may not prevent being infected with the virus thus wearing a mask and following other public health protocols will be necessary. According to Serum Institute of India CEO, India has a capacity of 40 million monthly doses at the moment and is expected to increase to 100 million in subsequent months. Moreover the vaccine could cost between Rs.500-600 in the private market for the general public. The vaccine is expected to be available to the vulnerable population by January-February and to the general public by March-April. This timeline depends on the results of the Oxford-Astrazeneca vaccine, given by the UK authorities-MHRA and approval of emergency use by European EMEA. there probably won’t be a choice of vaccine. State health departments will likely be coordinating the ordering and distribution of doses, without knowing which vaccines they will receive


Please enter your comment!
Please enter your name here

Enable Google Transliteration.(To type in English, press Ctrl+g)